Author

Xuying Wang

Institution: Yancheng Institute of Technology

Observed institution: Yancheng Institute of Technology

OpenAlex ID: A5111775319

Novel Multifunctional Aldose Reductase Inhibitors Based on Quinoxalin‐2(1 H )‐one Scaffold for Treatment of Diabetic Complications: Design, Synthesis, and Biological Evaluation

2025 · Xin Hao, Xuying Wang, et al. · Chemistry & Biodiversity · 8

Discovery of substituted quinoxaline-2,3(1H,4H)‑dione as potent, selective, and orally bioavailable aldose reductase inhibitors targeting for diabetic complications

2026 · Zhongfei Han, Qianxi Jiang, et al. · Journal of Molecular Structure · 2

Novel hydroxyacetimidamide derivatives of quinolin-4(1H)-one as dual inhibitor targeting AKR1B1/α-glucosidase for treatment of diabetic complications: Design, synthesis and biological evaluation

2026 · Xin Hao, Xuying Wang, et al. · Journal of Molecular Structure · 1

Construction of 1,3,4-oxadiazolines bearing CF 3 -quaternary centers via amino-assisted [3 + 2] cycloadditions

2024 · Yannan Zhu, Fang Bo, et al. · Organic & Biomolecular Chemistry · 1

Benzo[d]isothiazol-3(2H)-one 1,1-dioxide as potent and selective aldose reductase inhibitors with anti-α-glucosidase activity: Rational design, synthesis, and molecular insights

2026 · Xuying Wang, Qianxi Jiang, et al. · Journal of Molecular Structure

Works count: 5

Citation count: 12

H-index: 2

I10-index: